The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
from NYT > Health https://ift.tt/n30ZYBx
Subscribe to:
Post Comments (Atom)
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing... -
Captive animals sometimes need a transfusion, but the typical approach to blood banking isn’t practical for zoos and aquariums. One veterina...
-
The health secretary said he would prioritize studies into environmental causes while harshly discounting other factors scientists say are l...
No comments:
Post a Comment